|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pilkington G, Boland A, Brown T, Oyee J,
Bagust A and Dickson R: A systematic review of the clinical
effectiveness of first-line chemotherapy for adult patients with
locally advanced or metastatic non-small cell lung cancer. Thorax.
70:359–367. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pacurari M, Addison JB, Bondalapati N, Wan
YW, Luo D, Qian Y, Castranova V, Ivanov AV and Guo NL: The
microRNA-200 family targets multiple non-small cell lung cancer
prognostic markers in H12299 cells and BEAS-2B cells. Int J Oncol.
43:548–560. 2013.PubMed/NCBI
|
|
7
|
Ahmad A, Maitah MY, Ginnebaugh KR, Li Y,
Bao B, Gadgeel SM and Sarkar FH: Inhibition of Hedgehog signaling
sensitizes NSCLC cells to standard therapies through modulation of
EMT-regulating miRNAs. J Hematol Oncol. 6:772013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hashimoto Y, Kim DJ and Adams JC: The
roles of fascins in health and disease. J Pathol. 224:289–300.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hwang JH, Smith CA, Salhia B and Rutka JT:
The role of fascin in the migration and invasiveness of malignant
glioma cells. Neoplasia. 10:149–159. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao J, Zhou Y, Zhang Z, Tian F, Ma N, Liu
T, Gu Z and Wang Y: Upregulated fascin1 in non-small cell lung
cancer promotes the migration and invasiveness, but not
proliferation. Cancer Lett. 290:238–247. 2010. View Article : Google Scholar
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
12
|
Patnaik SK, Kannisto E, Knudsen S and
Yendamuri S: Evaluation of microRNA expression profiles that may
predict recurrence of localized stage I non-small cell lung cancer
after surgical resection. Cancer Res. 70:36–45. 2010. View Article : Google Scholar
|
|
13
|
Rui W, Bing F, Hai-Zhu S, Wei D and
Long-Bang C: Identification of microRNA profiles in
docetaxel-resistant human non-small cell lung carcinoma cells
(SPC-A1). J Cell Mol Med. 14:206–214. 2010. View Article : Google Scholar
|
|
14
|
Feng B, Wang R and Chen LB: Review of
miR-200b and cancer chemosensitivity. Biomed Pharmacother.
66:397–402. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tryndyak VP, Ross SA, Beland FA and
Pogribny IP: Down-regulation of the microRNAs miR-34a, miR-127, and
miR-200b in rat liver during hepatocarcinogenesis induced by a
methyl-deficient diet. Mol Carcinog. 48:479–487. 2009. View Article : Google Scholar
|
|
16
|
Li A, Omura N, Hong SM, Vincent A, Walter
K, Griffith M, Borges M and Goggins M: Pancreatic cancers
epigenetically silence SIP1 and hypomethylate and overexpress
miR-200a/200b in association with elevated circulating miR-200a and
miR-200b levels. Cancer Res. 70:5226–5237. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang HF, Zhang K, Liao LD, Li LY, Du ZP,
Wu BL, Wu JY, Xu XE, Zeng FM, Chen B, et al: miR-200b suppresses
invasiveness and modulates the cytoskeletal and adhesive machinery
in esophageal squamous cell carcinoma cells via targeting
Kindlin-2. Carcinogenesis. 35:292–301. 2014. View Article : Google Scholar
|
|
18
|
Peng F, Jiang J, Yu Y, Tian R, Guo X, Li
X, Shen M, Xu M, Zhu F, Shi C, et al: Direct targeting of
SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma
tumourigenesis and metastasis. Br J Cancer. 109:3092–3104. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu J, Lu Y, Cui D, Li E, Zhu Y, Zhao Y,
Zhao F and Xia S: miR-200b suppresses cell proliferation, migration
and enhances chemosensitivity in prostate cancer by regulating
Bmi-1. Oncol Rep. 31:910–918. 2014.
|
|
20
|
Yoneyama K, Ishibashi O, Kawase R, Kurose
K and Takeshita T: miR-200a, miR-200b and miR-429 Are onco-miRs
that Target the PTEN gene in endometrioid endometrial carcinoma.
Anticancer Res. 35:1401–1410. 2015.PubMed/NCBI
|
|
21
|
Fang S, Zeng X, Zhu W, Tang R, Chao Y and
Guo L: Zinc finger E-box-binding homeobox 2 (ZEB2) regulated by
miR-200b contributes to multi-drug resistance of small cell lung
cancer. Exp Mol Pathol. 96:438–444. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Feng B, Wang R, Song HZ and Chen LB:
MicroRNA-200b reverses chemoresistance of docetaxel-resistant human
lung adenocarcinoma cells by targeting E2F3. Cancer. 118:3365–3376.
2012. View Article : Google Scholar
|
|
23
|
Chen DQ, Pan BZ, Huang JY, Zhang K, Cui
SY, De W, Wang R and Chen LB: HDAC 1/4-mediated silencing of
microRNA-200b promotes chemoresistance in human lung adenocarcinoma
cells. Oncotarget. 5:3333–3349. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen DQ, Huang JY, Feng B, Pan BZ, De W,
Wang R and Chen LB: Histone deacetylase 1/Sp1/microRNA-200b
signaling accounts for maintenance of cancer stem-like cells in
human lung adenocarcinoma. PLoS One. 9:e1095782014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Park SH, Song JY, Kim YK, Heo JH, Kang H,
Kim G, An HJ and Kim TH: Fascin1 expression in high-grade serous
ovarian carcinoma is a prognostic marker and knockdown of fascin1
suppresses the proliferation of ovarian cancer cells. Int J Oncol.
44:637–646. 2014.PubMed/NCBI
|
|
26
|
Zheng K, Liu W, Liu Y, Jiang C and Qian Q:
MicroRNA-133a suppresses colorectal cancer cell invasion by
targeting Fascin1. Oncol Lett. 9:869–874. 2015.PubMed/NCBI
|
|
27
|
Feng Y, Zhu J, Ou C, Deng Z, Chen M, Huang
W and Li L: MicroRNA-145 inhibits tumour growth and metastasis in
colorectal cancer by targeting fascin-1. Br J Cancer.
110:2300–2309. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Akanuma N, Hoshino I, Akutsu Y, Murakami
K, Isozaki Y, Maruyama T, Yusup G, Qin W, Toyozumi T, Takahashi M,
et al: MicroRNA-133a regulates the mRNAs of two invadopodia-related
proteins, FSCN1 and MMP14, in esophageal cancer. Br J Cancer.
110:189–198. 2014. View Article : Google Scholar :
|
|
29
|
Guo L, Bai H, Zou D, Hong T, Liu J, Huang
J, He P, Zhou Q and He J: The role of microRNA-133b and its target
gene FSCN1 in gastric cancer. J Exp Clin Cancer Res. 33:992014.
View Article : Google Scholar : PubMed/NCBI
|
